105 related articles for article (PubMed ID: 25205377)
1. Application of human bone marrow-derived mesenchymal stem cells in the treatment of radiation-induced Gastrointestinal syndrome.
Yang C; Dai W; Chen H; Wu B
Sci China Life Sci; 2014 Dec; 57(12):1177-82. PubMed ID: 25205377
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice.
Saha S; Bhanja P; Kabarriti R; Liu L; Alfieri AA; Guha C
PLoS One; 2011; 6(9):e24072. PubMed ID: 21935373
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome.
Chapel A; Bertho JM; Bensidhoum M; Fouillard L; Young RG; Frick J; Demarquay C; Cuvelier F; Mathieu E; Trompier F; Dudoignon N; Germain C; Mazurier C; Aigueperse J; Borneman J; Gorin NC; Gourmelon P; Thierry D
J Gene Med; 2003 Dec; 5(12):1028-38. PubMed ID: 14661178
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells – A new hope for radiotherapy-induced tissue damage?
Nicolay NH; Lopez Perez R; Debus J; Huber PE
Cancer Lett; 2015 Oct; 366(2):133-40. PubMed ID: 26166559
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.
Reinders ME; Roemeling-van Rhijn M; Khairoun M; Lievers E; de Vries DK; Schaapherder AF; Wong SW; Zwaginga JJ; Duijs JM; van Zonneveld AJ; Hoogduijn MJ; Fibbe WE; de Fijter JW; van Kooten C; Rabelink TJ; Roelofs H
Cytotherapy; 2013 Jun; 15(6):663-72. PubMed ID: 23419679
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell therapy for cutaneous radiation syndrome.
Akita S; Akino K; Hirano A; Ohtsuru A; Yamashita S
Health Phys; 2010 Jun; 98(6):858-62. PubMed ID: 20445394
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.
Madonna R; Taylor DA; Geng YJ; De Caterina R; Shelat H; Perin EC; Willerson JT
Circ Res; 2013 Sep; 113(7):902-14. PubMed ID: 23780385
[TBL] [Abstract][Full Text] [Related]
9. Presence of osteoclast precursor cells during ex vivo expansion of bone marrow-derived mesenchymal stem cells for autologous use in cell therapy.
Allers C; Lasala GP; Minguell JJ
Cytotherapy; 2014 Apr; 16(4):454-9. PubMed ID: 24176545
[TBL] [Abstract][Full Text] [Related]
10. Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device.
Otsuru S; Hofmann TJ; Olson TS; Dominici M; Horwitz EM
Cytotherapy; 2013 Feb; 15(2):146-53. PubMed ID: 23321326
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
[TBL] [Abstract][Full Text] [Related]
12. Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering.
Ohgushi H
Expert Opin Biol Ther; 2014 Feb; 14(2):197-208. PubMed ID: 24308323
[TBL] [Abstract][Full Text] [Related]
13. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
14. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
Isaikina Y; Shman T
Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes.
Lee HJ; Jung J; Cho KJ; Lee CK; Hwang SG; Kim GJ
Differentiation; 2012 Oct; 84(3):223-31. PubMed ID: 22885322
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-based therapy for type 1 diabetes.
Wu H; Mahato RI
Discov Med; 2014 Mar; 17(93):139-43. PubMed ID: 24641956
[TBL] [Abstract][Full Text] [Related]
18. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
Bhonde RR; Sheshadri P; Sharma S; Kumar A
Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?
El Omar R; Beroud J; Stoltz JF; Menu P; Velot E; Decot V
Tissue Eng Part B Rev; 2014 Oct; 20(5):523-44. PubMed ID: 24552279
[TBL] [Abstract][Full Text] [Related]
20. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations.
Wang J; Liao L; Wang S; Tan J
Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
